Serum osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection.
about
Role of Osteopontin in Liver DiseasesHyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologiesOxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesisEpigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis.Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localizationA network pharmacology approach to discover active compounds and action mechanisms of San-Cao Granule for treatment of liver fibrosisNon-invasive assessment of liver fibrosis and prognosis.A systematic review and meta-analysis of HCV clearance.Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.The Roles of Matricellular Proteins in Oncogenic Virus-Induced Cancers and Their Potential Utilities as Therapeutic Targets.Presepsin: A potential biomarker of PJI? A comparative analysis with known and new infection biomarkers.Is Osteopontin a Friend or Foe of Cell Apoptosis in Inflammatory Gastrointestinal and Liver Diseases?Proton nuclear magnetic resonance-based metabonomic models for non-invasive diagnosis of liver fibrosis in chronic hepatitis C: Optimizing the classification of intermediate fibrosis.Serum osteopontin is a predictor of prognosis for HBV-associated acute-on-chronic liver failure.Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented ReviewSerum Interleukin-8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseThe osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication
P2860
Q26738504-956A5F99-4ECA-41E7-ACB1-B17C5CBF768BQ26752723-6178BB74-65D9-492D-B760-8EA3FB5C3EA5Q28075646-2A4180CD-1F7F-4F5E-AEF9-17FE4D22B29EQ36217669-3C39CD7F-C83D-49FA-AAA0-688ED7B112BDQ36578825-7966C8A0-4201-432C-8C39-D7E784242A4EQ36617742-5E472A12-0760-4F36-8E4A-DCB93725F33FQ38588078-E56B6046-3B20-436C-A5C4-32762BA986D3Q38928083-C754771E-96F1-49BD-916D-16673C5BC274Q39791661-AADCB933-7263-469B-B9A6-4F977E65CCBEQ45325755-5C4544C7-01E0-4CA6-A45F-6C9171569932Q47282539-F627152E-2DDE-464D-9C12-2D9036D1E935Q48365200-144D089C-9894-41ED-8C63-415CD6EC132DQ48513520-2CDF2B0E-75F7-4DB9-9E5C-6537903AB7F9Q49412631-F1204A40-E553-45A6-8E6D-154390AC2AF4Q57066901-E5B7AAB3-96D4-4D2D-9730-DC952F7094D2Q58552833-3E2C787F-0E9B-41FA-B8E4-CBE20C4B3A41Q58769353-ED22D42D-4F3F-4FB1-ADD3-374EE22C3ECF
P2860
Serum osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Serum osteopontin predicts deg ...... h hepatitis C virus infection.
@ast
Serum osteopontin predicts deg ...... h hepatitis C virus infection.
@en
type
label
Serum osteopontin predicts deg ...... h hepatitis C virus infection.
@ast
Serum osteopontin predicts deg ...... h hepatitis C virus infection.
@en
prefLabel
Serum osteopontin predicts deg ...... h hepatitis C virus infection.
@ast
Serum osteopontin predicts deg ...... h hepatitis C virus infection.
@en
P2093
P2860
P1433
P1476
Serum osteopontin predicts deg ...... h hepatitis C virus infection.
@en
P2093
Mikihiro Tsutsumi
Mutsumi Tsuchishima
Nobuhiko Hayashi
Nobuyuki Toshikuni
Takashi Saito
Tomiyasu Arisawa
Yasuhiro Matsue
P2860
P304
P356
10.1371/JOURNAL.PONE.0118744
P407
P577
2015-03-11T00:00:00Z